Lecture 6 Pharmaceutical inspection topic of interest Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

on-site inspection

A

inspectors physically present at manu site to access company’s compliance with GMP or GXP standards and other regulatory requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

remote inspection

A
  • mimics on-site inspection, enabled by e-tech
  • strives to mimic on-site inspection in terms of formate, time-frame and overall rigor
  • offline, virtual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

desktop inspection

A

form of remort inspection based on review of documentary evidence provided by the company
- largely ‘paper-based’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

arrangements for remote inspections

A
  1. agree on virtual conference (inspection) platform
  2. assure strong internet/wifi connectivity and audio-visual resolution
  3. know the parties involved and their roles
  4. agree on inspection time and duration, and timezone for remote overseas inspections
  5. make arrangements relating to confidentiality, security and access to file-sharing platforms
  6. agree on safety arrangements such as use of handphones and video cameras: potential cross-contamination and explosion hazards
  7. deal with document system, comprising paper and electronic records: photocopiers, printer, tech staff on standby
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

challenges of remote inspection

A
  1. existing e-tech limitation due to unstable internet connectivity and poor AV resolution
  2. limited resources at manufacturing sites split teams)
  3. overal slower response time to complete remote inspection
  4. lack of body language (gesture, tone, smell) can distort discussion
  5. difficult to inspect utilities and Manu operations (eg. clean room, computerized system)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

benefits of PIC/S membership

A
  1. reduced duplication of GMP inspections

2. increased opportunity for collaborations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

spin off from SG PIC/S membership

A
  1. signing of SG-AUS MRA on GMP inspection 2001
  2. legal recognition of SG Pharma inspection system by AUS and vice-vera
  3. brought about ‘work-sharing’ program amongst TGA partners
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TGA partners

A
  • Swissmedic
  • NZ Medsafe
  • Health Canada
  • Sg HSA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

benefits of ASEAN MRA on GMP inspection

A
  1. avoids duplication of Pharma inspections within ASEAN
  2. saves time, resources and cost for Manu and regulators
  3. facilitates trade in medicinal product cross ASEAN
  4. quicker access of med products by ASEAN pt
  5. harmonises ASEAN inspection system too that of PIC/S
  6. increase attractiveness of ASEAN to regulators and investors from Asia and other parts of the world
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

objective ot ASEAN KSC

A

establish a register of ASEAN listed inspection services (LIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MRA

A

mutual recognition agreement

  • take relatively long time to negotiate/conclude
  • usually negotiated under larger platform of free trade agreement
  • involves, regulators, lawyers, trade and industry representatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

frame work of PIC/S GMP inspection reliance includes

A
  1. having MRA on GMP inspection in place
  2. recognition of GMP compliance status of a facility located within territory of a PIC/S participating authority
  3. Recognition of inspection outcome by a hosting inspectorate which has been assessed under a robust framework (eg. PIC/S JAP or JRP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

WHO good reliance practices

A
  1. covers reliance activity in regulation of med products
  2. spans entire product life cycle
  3. intended for all national regulatory authorities regardless of their maturity levels and resources
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

product life cycle includes

A

GMCPLL

  1. GMP inspection
  2. market authorization
  3. clinical trials oversight
  4. product quality surveillance and vigilance
  5. lab testing
  6. lot release (off vax)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is reliance described by WHO good reliance practices

A
  • an act whereby an NRA takes into account an assessment performed by another NRA in reaching its own decision
  • relying NRA remains independent, responsive, and accountable for decision taken, even as it relies on assessment of another NRA
  • not a less stringent form of regulation or an outsourcing of regulatory mandate
  • hallmark of Morden and efficient regulatory authority and smart regulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

advantages of nanomeds

A
  1. effective in targeting difficult to reach (tumor) sites
  2. imported solubility, bioavailability and reduced side effects
  3. achievement of same therapeutic effect with smaller dose
    - special properties de to its size, shape and surface chem
17
Q

GMP and safety concerns of nanomeds

A

free nanoparticles released into the environment during Manu are potential health and cross contamination hazard

18
Q

limitation of conventional product testing

A
  1. only test on a representative sample size
  2. can test onyx if you know the analyze and have a test method
  3. can test only if test method is specific, accurate and reliable